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Summary During the routine serial passage of over 30 human tumour xenografts in athymic (nu. nu.) mice
over a period of 6 years the induction of murine fibrosarcomas at the site of transplantation has been
observed on three occasions. In two cases it has been possible to follow the development of these tumours
over successive transplant generations. These sarcomas had growth rates, tumour karyotypes and isoenzyme
patterns which clearly distinguished them from the original human xenografts.
Human tumour xenografts are now an established
model for tumour biology and therapy studies
(Steel et al., 1983). Although a number of different
types of immunodeficient animals have been used
as hosts for the transplant tumours (Castro, 1972;
Steel et al., 1978; Rygaard & Povlsen, 1969; Lozzio
et al., 1976; Festing et al., 1978) the athymic nude
mouse mutant (nu.nu.) is now the most popular. A
number of workers have demonstrated that the
tumours tend to retain the morphology of the
original explant in successive transplants in spite of
the rodent stromal and vascular components of
these tumours (Sharkey et al., 1978; Povlsen et al.,
1982; Sebesteny et al., 1979).
Athymic mice can exhibit a high incidence of
malignant lymphomas (Custer et al., 1973) and it
has been suggested that this is associated with
chronic antigenic stimulation (Baird et al., 1982).
The occurrence of lymphomas has also been
directly linked to the transplantation of human
tumours (Gautsch et al., 1980). The apparent
induction of malignant lymphoma by human xeno-
grafts could conceivably become a problem in the
routine passage of human tumours in mice as each
transplant generation carries the risk of propagat-
ing the induced lymphoma as well as, or instead of,
the human tumour under investigation (Figure 1).
Types of 'spontaneous' tumour other than
malignant lymphoma are rare in athymic mice
(Sharkey et al., 1982). Houghton and Taylor (1978)
described the occurrence, during the routine serial
passage of a human colorectal tumour in surgically
immune deprived mice, of a tumour which had a
different LDH isoenzyme pattern and karyotype
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from that which was expected. Although they also
reported that this tumour had a different histo-
logical pattern from the original tumour no details
were given. Beattie et al. (1982) reported the
occurrence of two cases of murine sarcoma
induction during the course of serial passage of 50
human tumour xenografts in anthymic mice over a
period of 5 years. Our own experience with over 30
human xenografts over a 6 year period, some of
which have been through more than 30 passages in
athymic mice, has revealed the occurrence of 3
cases of murine sarcoma induction. This paper




Athymic nude mice (nu.nu.) on a random TO
background were bred and maintained in flexible
film plastic isolators to minimise disease from
infectious agents. Heterozygous litter mates (nu.+.)
were used to test the transformed tumours for their
ability to grow in immunocompetent animals.
Tumours
Explants from patients at the Royal Marsden
Hospital were implanted as small (1-2mm3) frag-
ments, subcutaneously into the right flank of 12-
week old mice. Serial passage was carried out when
the tumours had reached a size of -1 cm3.
Histology
Thick slices of tumour (3mm) taken at each serial
passage were fixed in Bouin's fluid. Paraffin
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sections (4gm) were prepared and stained with
haematoxylin and eosin.
Karyotyping
Mice were injected i.p. with 4 ugkg- of colcemid
(Sigma) and killed by cervical dislocation 3 h later.
Single cell suspensions of the tumours were
prepared, fixed in methanol/acetic acid and stained
with Giemsa.
LDH isoenzymes
Tumours were homogenised in ice cold 50mm Tris-
HCI buffer pH 8.0 with 0.1% Triton X-100. The
homogenates were centrifuged and the supernatants
were placed on cellulose acetate plates (Helena
Laboratories) and subjected to electrophoresis at
200V for 20min after which time the plates were
incubated with a solution containing NAD, lactate,
PMS and MTT in 1.0M Tris-HCI buffer for 15min
to demonstrate the LDH isoenzymes.
Figure 1 Ovarian carcinoma xenograft. Nests of
carcinoma (arrows) are surrounded by a lymphoma of
mouse origin. This mouse also had lymphoma in the
liver, lung, kidney and spleen. H&E ( x 60).
Results
PXN 21
This was an oat cell carcinoma of the lung. At the
first passage in athymic mice the tumour took 190
days to reach a size suitable for further transplanta-
tion. Subsequently passages 2 and 3 took 160 days
and 427 days respectively but the time to
transplantable size at passge 4 was reduced to only
15 days. The mean passage time for passages 4-12
was 17 days. The histological appearance of the
original explant and first two passages was very
similar, small anaplastic cells with little cytoplasm
tending to oat cell morphology with a fair
proportion of stromal tissue randomly arranged in
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Figure 2 Oat cell carcinoma of the lung. Explant
from patient: Small cells tending to oat cell
morphology. H&E (x 300).
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Figure 3 Carcinoma from Figure 2 after first passage
in an athymic mouse. Cellular morphology is very
similar but there is less stromal material. H&E.
(x300).
between (Figures 2 and 3). In passage 3, however,
the stromal component was much greater with a
more regularly arranged fibroblastic pattern. This
'stromal' tissue had a high rate of mitoses. The
anaplastic cells were arranged in small nests within
this fibroblastic mass (Figure 4) but retained the
morphology of the original tumour cells. By
passage 4 no small anaplastic cells of the original
type could be found. What appeared to be the
stromal component showed considerable change;
there was some heterogeneity with cells ranging
from fusiform shape to round cells with abundant
cytoplasm and there was a large number of mitotic
figures. The tumour was invasive penetrating both
the muscularis (Figure 5) and the dermis.
The histological evidence of invasiveness was
supported by the gross morphology. Usually a
human tumour xenograft when implanted sub-
cutaneously in athymic mice grows as a well-IN VIVO MALIGNANT TRANSFORMATION 795
Figure 6 Mouse lung from passage 5. A plug of Fiur 4 Thr.asg fcrioai tyi tumour cells IS occludin a small blood vessel. H&E.
mice. Original tumours have similar morphology but (x 150).
are arranged in isolated nests within a mass of
proliferating mouse fibroblastic tissue. H&E. ( x 60).
Figure 5 Mouse sarcoma cells invading the cutaneous Figure 7 Metaphase spread from transformed tumour
muscularis. Passage 4. H&E. ( x 300). demonstrating the typical telocentric mouse karyotype.
Giemsa. (x 10,000).
encapsulated mass with no damage to surrounding
tissue even when the tumour is quite large and it is
easily removed at transplantation. The tumour at
passage 4 in this case caused quite severe
ulceration of the skin of the mouse and was
difficult to remove cleanly as a single mass. At
passage 5 some tumours were allowed to grow
beyond the normal transplant size and in the
animals bearing these tumours, metastatic lesions
were found in the lung parenchyma and a
pulmonary arteriole (Figure 6).
Karyological studies on these tumours gave
metaphase spreads with the typical telocentric
appearance of murine chromosomes (Figure 7). In
the true xenograft although occasional mouse meta-
phase figures may be found, the vast majority of
metaphase figures were human (Figure 8).
The normal LDH isoenzyme patterm for human
tissue is five types, designated H4, H3M, H2M2,
HM3, H4, which have been named according to the
Figure 8 Metaphase spread from true human tumour
xenograft with an abnormal by clearly human
karyotype. Giemsa. ( x 6,000).796 S. SPARROW et al.
relative amounts in heart and muscle tissue of man.
Human tumour xenografts show this typical pattern
although extra faint bands may be visible which are
the contribution of the host stromal tissue. This is
clearly seen in Figure 9. In the transformed
tumours only the mouse isoenzymes are visible.
Figure 9 Electrophoresis of tumours and staining to
reveal LDH isoenzymes. The origin is a 0. Lane 'a' is
a human tumour directly explanted from a patient and
shows the 5 characteristic isoenzymes. Lane 'f' is the
transformed tumour and shows the 5 murine
isoenzymes. Lanes 'b-e' show various xenografts all
of which show the 5 human isoenzymes, although faint
bands at mouse positions 4 and 5 can be seen in some
of them. This is presumably contributed by the mouse
stromal component ofhuman tumour xenografts.
At passage 6 tumour fragments were implanted
into 6 nude (nu.nu.) mice and 6 heterozygous litter
mates (nu. +.). Tumours grew in both sets of mice
although the growth rate was slower in the
heterozygotes.
PXN 27
This was an ovarian carcinoma and the explant was
composed of pleomorphic cells many of which were
multinucleate giant cells which were loosely
arranged in an adenomatous pattern in stromal
tissue with a high inflammatory cell component.
The histological appearance of the first five
passages of this tumour in nude mice was very
similar to that of the explant. At passage 6 there
was a much more fibroblastic looking stromal
component with a high mitotic index, and by
passage 7 the tumour mass was composed entirely
of fibroblastic cells. This tumour also caused
ulceration of the skin of the mice and local invasion
of the muscularis was seen microscopically. The
passage intervals of this tumour were more variable
starting at 231 days and 317 days for the first two
passages, reducing to 70, 67, 40 and 48 days for
passges 3, 4, 5 and 6 respectively. Passage 7 was 23
days and all subsequent passages were consistently
under 25 days.
The passage intervals for PXN 21 and PXN 27
are given in Table I together with the mean passage
intervals for 20 tumour xenografts of various types
in which evidence of mouse cell transformation was
not identified.
Table I Successive passage intervals (days) for tumours
PXN 21 and PXN 27 compared with the mean interval
for 20 different xenografts which retained human tumour
morphology. Both tumours are characterised by very long
passage intervals before transformation and very short
intervals thereafter
Passage no. 1 2 3 4 5 6 7 8 9+
PXN 21 190 160 427 15 13 16 13 19 17+4
PXN 27 231 317 70 67 40 48 23 21 17+4
All xenografts 183 169 127 84 95 90 79 87 80+2
One other case of apparent malignant
transformation has been seen. A human malignant
melanoma xenograft had undergone 8 passages in
athymic nude mice when histological examination
revealed a number of small groups of cells of the
original explant type surrounded by a mass of
highly proliferative fibroblastic tissue. This
particular tumour had not been used for further
transplantation in mice and no further incidents of
transformation were seen with this tumour line.
Discussion
Goldenberg and Pavia (1980) demonstrated that
when some human tumour xenografts were grown
in vitro the mouse stromal cells exhibited malignant
transformation. Although they were unable to
demonstrate the transformation in vivo they
concluded that it was likely that the transformation
occurred before being cultured in vitro. Houghton
and Taylor (1978) observed induction of a mouse
tumour in 1 out of 6 adenocarcinoma xenografts
passaged in athymic mice and Beattie et al. (1982)
characterised two such transformations. No details
were given in either of these reports of gross
findings, or the presence of invasion and metastasesIN VIVO MALIGNANT TRANSFORMATION 797
with the transformed tumours. The changes
observed in the gross morphology, particularly the
rapid growth and skin ulceration, should alert
workers to the occurrence of malignant
transformation, as lack of local invasion and
relatively slow growth is characteristic of human
tumour xenografts. Such malignant transformations
may be much more difficult to detect in other
xenograft models; rat tumour xenografts in athymic
mice, for example, may show rapid growth and
local invasion even at first passage in athymic mice
(personal observation).
The confirmation of malignant transformation by
karyology is necessary although other methods of
monitoring may be more convenient (Beattie et al.,
1982). The LDH isoenzymes studied show that true
xenografts do have a small murine component
contributed by the stromal tissue but the change in
transformed tumour patterns is quite obvious.
The ability of the tumours to grow in immuno-
competent litter mates of nude mice also indicates
the murine origin of these tumours.
The mechanisms by which malignant
transformation may occur is still not clear but
Beattie et al. (1982) found high reverse transcriptase
activity and intercellular type C virus particles
suggesting the presence of murine viruses in their
transformed tumour, and it is interesting that the
induction of murine leukaemia virus (MuLV)
described by Gautsch et al. (1980) was by an oat
cell carcinoma. Another possibility is that the
human xenografts produced large amounts of
tumour growth factor which has been shown to
cause morphological changes of normal cells to a
malignant phenotype (Todaro et al., 1980). A third
possibility is the formation of hybridomas between
malignant human cells and normal mouse
fibroblasts with subsequent deletions of the human
chromosomes.
Whatever the mechanisms it is important that
those working with xenografts should be aware of a
phenomenon which may prove useful in the future
in understanding the nature of malignant
transformation.
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